Back to 
UBS Group AG
UBS Group AG
LIMN5 quarters
Position history for UBS Group AG's holdings in LIMINATUS PHARMA INC.
Yes. Ubs holds 16,730 shares of LIMN (Liminatus Pharma), worth $1,840, as of its Q2 2026 13F filing. It reduced the position by 37,848 shares (-69.4%) from Q1 2026. Ubs has held LIMN since Q2 2025, across 5 quarterly 13F filings.
Current Value
$1,840
Current Shares
16,730
Total Value Change
-$349,229
Total Shares Change
-14,756
Quarter-by-Quarter History
Other major holders of LIMN: VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, BlackRock, Inc.